THERAPIES OF PURULENT MASTITIS IN CATS
รหัสดีโอไอ
Creator V.V Chekrysheva, I.A. Rodin
Title THERAPIES OF PURULENT MASTITIS IN CATS
Contributor -
Publisher TuEngr Group
Publication Year 2563
Journal Title International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies
Journal Vol. 11
Journal No. 10
Page no. 11A10D: 1-7
Keyword Sick cats, Female cats, Breast pathology, Mammary gland, Purulent form of mastitis, Ill cats, Hematological parameters, Inflammation.
URL Website http://TuEngr.com/Vol11_10.html
Website title ITJEMAST V11(10) 2020 @ TuEngr.com
ISSN 2228-9860
Abstract A comparative analysis of the most common methods of treating mastitis in cats is carried out, and the incidence of mastitis in cats among the entire obstetric and gynecological pathology is studied. Currently, mastitis in cats is an urgent problem, due to the high cost of treatment costs, the possible death of the cat itself, as well as the shortage of litter of nutrients due to the lack of milk in the female. Possible complications after cats are ill with a purulent form of mastitis include a lack of lactation. Thus, the problem of finding rational methods for treating purulent forms of mastitis in cats is relevant not only for veterinarians but also for owners of animals. Mastitis is the most common pathology among cats and makes up 36.5%. In the course of studies, it was revealed that the purulent form of mastitis occurs in 41% of rays among all forms of mastitis in cats. The clinical picture with a purulent form of mastitis is pronounced: the animal is depressed, refuses to eat, body temperature is increased to 40?C, and pulse and respiratory rate are increased. Signs of inflammation in the mammary gland are also pronounced. The mammary gland is enlarged, hot, hyperemic, swollen, soreness pronounced. A secretion of pus is secreted from the nipples with an unpleasant odor of white-yellow color. Also during the operation was investigated for therapeutic efficacy ?omplex schemes s treatment using antibiotic Sinuloks and non-steroidal anti-inflammatory drug Ainil. The therapeutic efficacy of this regimen reaches 100% within 5 days. A comprehensive treatment regimen using m antibacterial drug Kobactan 2.5% and non-steroidal anti-inflammatory drug Meloxivet 2% is therapeutically effective in 100% of cases for 5 days. The animals of the control group used the antibacterial drug Bicillin 3 twice. Such therapy showed very low therapeutic efficacy (40%).
tuengr group

บรรณานุกรม

EndNote

APA

Chicago

MLA

ดิจิตอลไฟล์

Digital File
DOI Smart-Search
สวัสดีค่ะ ยินดีให้บริการสอบถาม และสืบค้นข้อมูลตัวระบุวัตถุดิจิทัล (ดีโอไอ) สำนักการวิจัยแห่งชาติ (วช.) ค่ะ